MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from
at-the-market offering
$7,202,016
Proceeds from private
placement-Private Placement...
$2,715,000
Proceeds from private
placement-Private Placement...
$2,253,900
Proceeds from private
placement-Private Placement...
$1,509,796
Proceeds from private
placement-Private Placement...
$1,428,949
Proceeds from private
placement-Private Placement...
$1,079,998
Proceeds from exercise of
warrants
$901,578
Proceeds from private
placement-Private Placement...
$736,600
Proceeds from private
placement-Private Placement...
$694,999
Proceeds from exercise of
stock options
$844
Net cash provided by
financing activities
$17,906,547
Canceled cashflow
$617,133
Net (decrease)
increase in cash
-$943,267
Canceled cashflow
$17,906,547
Stock-based compensation
$2,631,652
Accrued expenses
$1,478,955
Restricted shares issued
for consulting and...
$618,813
Accounts payable
$519,720
Australia research and
development incentives...
-$80,410
Payment of offering
transactions costs
$617,133
Net cash used in
operating activities
-$18,844,598
Canceled cashflow
$5,329,550
Net effect of
foreign currency...
-$5,216
Net loss
-$22,396,172
Change in fair value of
warrant liability
-$1,198,210
Prepaid expenses and
other current assets
$579,766
Back
Back
Cash Flow
source: myfinsight.com
MAIA Biotechnology, Inc. (MAIA)
MAIA Biotechnology, Inc. (MAIA)